Key result
A higher C-reactive protein/albumin ratio at admission in patients with STEMI was significantly associated with impaired infarct-related artery patency before primary PCI (OR 1.56).
Why the study?
C-reactive protein and Albumin have been associated with poor prognosis in STEMI, but the relationship between infarct-related artery patency and C-reactive protein/Albumin ratio before p-PCI was not well defined.
Does the C-reactive protein/albumin ratio predict infarct-related artery patency before primary percutaneous coronary intervention in patients with STEMI?
Observational (n=822)
No
Does the C-reactive protein/albumin ratio predict infarct-related artery patency before primary percutaneous coronary intervention in patients with STEMI?
Answers are grounded in this paper and cite their sources.
The C-reactive protein/albumin ratio measured at admission is an independent predictor of impaired infarct-related artery patency (TIMI 0-1 flow) before primary PCI in patients with STEMI.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Akın et al. (2021) conducted an observational in ST-elevation myocardial infarction (STEMI) (n=822). C-reactive protein/albumin ratio (CAR) vs. TIMI flow 2-3 was evaluated on Impaired infarct-related artery (IRA) patency (TIMI flow 0-1) (OR 1.56, 95% CI 1.22-1.97, p=<0.001). A higher C-reactive protein/albumin ratio at admission in patients with STEMI was significantly associated with impaired infarct-related artery patency before primary PCI (OR 1.56).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: